Status:
COMPLETED
Induction of Allergen Specific Bronchial Immunotolerance After Specific Immunotherapy
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Mite Allergy
Allergic Asthma
Eligibility:
All Genders
5-17 years
Brief Summary
One aim of this study was to find out if the bronchial allergen provocation (BAP) is an appropriate method to appraise the efficacy of a specific immunotherapy (SIT). The investigators had one group o...
Detailed Description
One aim of this study was to find out if the bronchial allergen provocation(BAP) is an appropriate method to appraise the efficacy of a specific immunotherapy (SIT). We had one group of children recei...
Eligibility Criteria
Inclusion
- informed consent
- between 5 and 18 years of age
- diagnosis of a moderate Asthma bronchiale (I-II) in the last 12 months or rhino conjunctivitis
- no exacerbation \> 4 weeks before Visit
Exclusion
- age \< 5 years \> 18 years,
- FEV1 \< 75%
- no cooperation to undergo the BAP,
- exacerbation within the last 28 days before Visit
- other serious illnesses
- taking part in other clinical trials \< 30 days
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01479205
Start Date
July 1 2010
End Date
September 1 2011
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Paediatric Allergy and Pulmonology
Frankfurt am Main, Germany, 60590